Hormone Replacement Therapy Market to Witness Remarkable Growth, Anticipated to Attain US$ 12.4 Billion by 2028

According to the recent report by IMARC Group, titled "Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," offers a comprehensive analysis of the industry, which comprises insights on hormone replacement therapy market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global hormone replacement therapy market size reached US$ 8.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.26% during 2023-2028.

Hormone Replacement Therapy (HRT) is a medical treatment that involves replacing hormones, typically estrogen and progesterone in women, and testosterone in men, to alleviate symptoms associated with hormonal imbalances or deficiencies. HRT is commonly used to manage menopause-related symptoms in women, such as hot flashes, mood swings, and vaginal dryness. It can also be prescribed for transgender individuals to facilitate gender transition by aligning secondary sexual characteristics with their gender identity. In men, HRT is less common but may be recommended to address conditions like hypogonadism, where the body does not produce enough testosterone. HRT for men can help improve muscle mass, bone density, and overall well-being. HRT can be administered in various forms, including pills, patches, creams, gels, and injections, with the choice depending on the patient's specific needs and preferences.

Get a Sample Copy of this Report: https://www.imarcgroup.com/hormone-replacement-therapy-market/requestsample

Market Trends:

The global market is driven by the increased demand for HRT to alleviate symptoms, including hot flashes, mood swings, and osteoporosis. This demographic shift towards an older population is set to continue, ensuring a sustained market for HRT products and services. Moreover, the growing awareness and concerns about women's health have led to increased adoption of HRT. As medical research advances, more women are seeking hormone therapies as a means to manage their menopausal symptoms and reduce associated health risks. Additionally, HRT is also being explored for its potential in preventing chronic diseases such as cardiovascular conditions and cognitive decline, further expanding its market scope. Furthermore, lifestyle factors such as stress, obesity, and sedentary living have contributed to hormonal imbalances, fostering a need for HRT beyond menopausal women.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/hormone-replacement-therapy-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Abbott Laboratories
• Bayer AG
• Eli Lilly & Company
• Roche
• Hisamitsu Pharmaceutical Co. Inc.
• Merck
• Mylan
• Novartis
• Novo Nordisk
• Pfizer

Hormone Replacement Therapy Market Segmentation:

Our report has categorized the market based on region, product, route of administration and type of disease.

Breakup by Product:
• Estrogen Replacement Therapy
• Human Growth Hormone Replacement Therapy
• Thyroid Replacement Therapy
• Testosterone Replacement Therapy
• Others

Breakup by Route of Administration:
• Oral
• Parenteral
• Transdermal

Breakup by Type of Disease:
• Menopause
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Others

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.